TAO Synergies Inc
NASDAQ:TAOX

Watchlist Manager
TAO Synergies Inc Logo
TAO Synergies Inc
NASDAQ:TAOX
Watchlist
Price: 4.96 USD -5.16%
Market Cap: 35.4m USD

Operating Margin
TAO Synergies Inc

-5 327.7%
Current
-20 803%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5 327.7%
=
Operating Profit
-11m
/
Revenue
207.3k

Operating Margin Across Competitors

No Stocks Found

TAO Synergies Inc
Glance View

Market Cap
35.4m USD
Industry
Biotechnology

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer’s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson’s Disease, Traumatic Brain Injury, and Stroke. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2020-12-07. The firm's differentiated cryptocurrency treasury strategy is centered exclusively on the acquisition of TAO, the native cryptocurrency of Bittensor, a decentralized blockchain network for machine learning and AI.

TAOX Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5 327.7%
=
Operating Profit
-11m
/
Revenue
207.3k
What is the Operating Margin of TAO Synergies Inc?

Based on TAO Synergies Inc's most recent financial statements, the company has Operating Margin of -5 327.7%.

Back to Top